Announcements Trials
Browse Landscape

Phase

Phase 2 19Phase NA 1Phase 4 1Phase 3 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 19Liver Neoplasms 5Recurrence 2Liver Diseases 2Stomach Neoplasms 1Paraganglioma, Extra-Adrenal 1Liver Cirrhosis 1Endometrial Neoplasms 1Cholangiocarcinoma 1Carcinoma, Medullary 1Advanced Hepatocellular Carcinoma 1

Interventions

Radiofrequency Ablation 8Liver Transplantation 6Stents 4Cholangiopancreatography, Endoscopic Retrograde 3Radiotherapy 2Proton Therapy 2Electroporation 2Cisplatin 21-phenyl-3,3-dimethyltriazene 2toripalimab 1perfluoro-2,2,2',2'-tetramethyl-4,4'-bis(1,3-dioxolane) 1maltodextrin 1lenvatinib 1gemcitabine-oxaliplatin regimen 1camrelizumab 1apatinib 1X-Rays 1Therapeutic Irrigation 1Technetium Tc 99m Sulfur Colloid 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Standard of Care 1Sodium Chloride 1S 1 (combination) 1Resistance Training 1Radiosurgery 1Radionuclide Imaging 1Quality of Life 1Photons 1Photochemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Cholangiocarcinoma × lenvatinib × Clear all
NCT05215665 2024-12-11

GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma

Tianjin Medical University Cancer Institute and Hospital

Phase NA Unknown
146 enrolled
Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡